BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 26, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 31, 2018
View Archived Issues
ConSynance announces initiation of toxicology studies of CSTI-300 for IBS-D
Read More
Kissei announces negative topline results from the additional phase III study of KPS-0373
Read More
Academia and industry establish immune-mediated inflammatory diseases consortium
Read More
Researchers from U.S. patent 5-HT1F receptor agonists
Read More
Japanese researchers divulge RDH10 inhibitors
Read More
U7-snRNA therapy targeting the DUX4 gene developed for facioscapulohumeral muscular dystrophy
Read More
Researchers develop early-metastatic RCC model in chickens
Read More
Zai Lab and Crescendo enter licensing agreement for antibody VH domain therapeutic
Read More
GSK, Cloud Pharmaceuticals form drug discovery collaboration
Read More
FDA approves Xeljanz for moderate to severely active ulcerative colitis
Read More
GlycoMimetics enters agreement with NCI for pivotal study of uproleselan in AML
Read More
FDA grants priority review to Fycompa pediatric sNDA
Read More
Arix, Evotec and Fred Hutchinson establish academic bridge collaboration
Read More
Denali Therapeutics exercises option to acquire F-star Gamma
Read More
Treeway completes phase I study of oral formulation of TW-001 for ALS
Read More
Natural killer cell phenotype GAIA-102 has antitumor activity
Read More
Phase II EQUATOR study of filgotinib in psoriatic arthritis meets primary endpoint
Read More
FDA places clinical hold on IND for CTX-001 in sickle cell disease
Read More
Five Prime collaborates with Roche on IHC companion diagnostic assays
Read More
Encouraging results seen with pegilodecakin plus pembrolizumab or nivolumab in NSCLC, RCC patients
Read More
Syndax and Nektar collaborate to study combination of NKTR-214 with entinostat in melanoma
Read More
FDA clears Janssen to begin phase Ib/II trial of JNJ-68284528 in multiple myeloma
Read More
Researchers describe potent antitumoral activity of KY-1055, a dual anti-ICOS/PD-L1 antibody
Read More
